Neoadjuvant luteinizing-hormone-releasing hormone agonist plus low-dose estramustine phosphate improves prostate-specific antigen-free survival in high-risk prostate cancer patients: a propensity score-matched analysis
Crossref DOI link: https://doi.org/10.1007/s10147-015-0802-y
Published Online: 2015-02-15
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Koie, Takuya
Mitsuzuka, Koji
Yoneyama, Takahiro
Narita, Shintaro
Kawamura, Sadafumi
Kaiho, Yasuhiro
Tsuchiya, Norihiko
Tochigi, Tatsuo
Habuchi, Tomonori
Arai, Yoichi
Ohyama, Chikara
Yoneyama, Tohru
Tobisawa, Yuki
Text and Data Mining valid from 2015-02-15